Morgan Stanley’s iShares Evolved U.S. Innovative Healthcare ETF IEIH Stock Holding History
Bought
Maintained
Sold
Other funds holding IEIH
CAN
SWM
TRCT
PIMG
DAS
FP
ASN
Morgan Stanley's IEIH Position: Q2 2021 in Review
Morgan Stanley sold out of iShares Evolved U.S. Innovative Healthcare ETF (IEIH) in Q2 2021, closing a stake of 3,265 shares — an estimated $106K sold.
Morgan Stanley first reported a position in IEIH in Q4 2020 and held it in 2 quarters. The position peaked at $106K in Q1 2021. 15 funds tracked by Wall St. Rank hold IEIH as of Q2 2021.
- Morgan Stanley reported no remaining iShares Evolved U.S. Innovative Healthcare ETF position as of Q2 2021 after selling out during the quarter.
- Morgan Stanley sold 3,265 iShares Evolved U.S. Innovative Healthcare ETF shares in Q2 2021, an estimated $106K.
- Morgan Stanley first reported a position in iShares Evolved U.S. Innovative Healthcare ETF in Q4 2020 and held it in 2 quarters.
- Morgan Stanley's iShares Evolved U.S. Innovative Healthcare ETF position peaked at $106K in Q1 2021.
- 15 funds tracked by Wall St. Rank held iShares Evolved U.S. Innovative Healthcare ETF as of Q2 2021.
Based on Morgan Stanley's 13F filing for Q2 2021, filed 16 Aug 2021.